GlassScriptPrepare for your visit
Carol C Kavanaugh
Internal Medicine · Orland, CA · NPI 1689649444
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,420.59
in general payments reported to CMS, 2019-2025 · $117 in 2025
The $117 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $289.29
- Abbvie INC. $193.52
- Astrazeneca Pharmaceuticals LP $186.12
- Lilly USA, LLC $119.40
- Xeris Pharmaceuticals, INC. $75.27
- Supernus Pharmaceuticals, INC. $69.51
Drugs and devices associated with these payments
Gvoke Hypopen Vraylar Korlym Mounjaro Breztri Farxiga Eliquis Nurtec Odt Paxlovid Opsumit Evenity Jynarque
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Carol Kavanaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/166508/carol-c-kavanaugh